A Novel Non-Gadolinium Based Oral Contrast Agent for Liver MRI

Posted May 12, 2009 by Jan Trøst Jørgensen, MSc Pharm, PhD

At the recent European Congress of Radiology (ECR) in Vienna, March 6-10, 2009, the targeted MRI contrast agent CMC- 001 was exposed for the first time to the radiology community at a major congress, and the message about a convenient, well tolerated and effective oral non-gadolinium based agent was very well received by the audience.

Read full article